Life long Maverick: Seen it ALLl in 40 yrs of PROF. exposure as invest analyst/port mgr on the FRONT lines vs iHub Msg Bds.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SWAT TEAM on CALL to deal with OVERFLOWING Transgressions
since 2014 on too many FRONTS
For RE DIRECT
MASSIVE HOUSECLEANING
Extermination
MOLES
RATS
POMPOUS INDOLENT HI PROFILE FAILURES
Pretentious posters Hemming Hawing: ZERO value
Long winded verbosity is for abstracts
Doing it RIGHT on 1st Try MATTERS over the ABOVE since 2014!
MAVEN Bio99
What is the timeframe within which the FDA can expedite the approval of a cancer treatment that addresses a significant unmet medical need, such as recurrent glioblastoma, demonstrates life-saving efficacy where approaching 1,000 treatment trials have failed, and manifests moderate side effects, in the case of $NWBO DCVax, none. Noteworthy examples like Blinatumomab and Zanubrutinib received FDA approval within 75 and 84 days, respectively, and I have not even looked at this exhaustively...
I believe the UK's approval process for DCVax will conclude in under 60 days after submission (which the company has stated will occur the end of September) and will precede FDA approval. This will serve as the perfect backdrop, allowing the FDA to expedite its approval process even more rapidly than for the previously mentioned treatments. And the fact that the government has exploded the size of the CBER office into a super-office to evaluate cell therapies like DCVax is no accident. They want curative nontoxic treatments...
By the way, when do companies often submit cancer treatment BLA applications to the EMA? My analysis of 10 years of applications, reveals 30-40 days post FDA. So it's all going to happen quite quickly. Far faster than tens of millions of shares can be covered (or hundreds of millions of naked shares--if that is indeed the case). So good luck to all!
What is the timeframe within which the FDA can expedite the approval of a cancer treatment that addresses a significant unmet medical need, such as recurrent glioblastoma, demonstrates life-saving efficacy where approaching 1,000 treatment trials have failed, and manifests…
— Bio99 (@BIO99_BIO99) September 3, 2023
EPITAPH
With the amply displayed & documented……
UNPREPARED, IMPERMEABLY RIGID minds(??)
demonstrably UNADAPTABLE & INSOLENT mindsets since 2014
In traversing the expansively diverse but narrow STEEP Winding
TREACHEROUS TERRAIN in this unsuitable investment.
Too many Big EGO Cooks(???) not heeding early posted advice of DEEP PROFESSIONAL EXPERIENCES has been the result…….
Flogging, castigating, and even denigrating management never gets results.
Only mounting a difficult proxy contest may!
(I did it on the 1st try! Documented.) while others
pontificated & failed at prelims of organizational level.
That was the 3rd member of that TRIO.
No matter how much Pissing in the wind on every key encounter since 2014
NOBODY was equipped nor Experienced:
INFLATED EGOS of NEOPHYTES prevailed!
UNABLE to read or handle the handwriting on the wall
Since 2014 OVERWHELMING daily sweet NOTHINGS
(commiseration is NOT resolving)
due to the roundtriping $3 to $12 …CRATERED to FIFTEEN CENTS!
Huge LOSSES (both realized & UN realized)
CEO Linda F Powers had GINORMOUS LT Losses
OFFSET by HUGE gains selling Cognate to CRL
Nobody knew or posted till mine reveals the
EMPTY Due Diligence on ALL CRITICALS!!!
Highly unlikely for others to duplicate what LP DID
Clearly MASSIVE financial & personal dislocations
exacerbated by OTHER biotech CRATERS in their “portfolio”
AND detected LATE…real time MOLES 4 CHAOS
100% TRANSPARENCY for DARK Forces
Plus BIG EXASPERATED BRAIN DRAIN
HIDDEN(??) CARNAGE & DEVASTATION
The world is rife with PARASITES & PIRANHAS seen here
& identified early, Bully Pulpit Pied Piper NEOPHYTES went OVERBOARD
Herding FLOCKS off Yosemite FALLS
EASY Reading even of devious Personalities.
They will undoubtedly take credit for it’s rise from the DEAD.
FACTS vs SPIN
DiFFERENT STROKES for DIFFERENT FOLKS
Not forgetting what ENSUED below & from WHOM in what turned out to be their OWN CONTENTIOUS MIS READINGS & ILL LOGICAL befuddlements that underscores still unaddressed MYOPIA seen in this waste land since 2014!
Time sequenced progression & rampant obstinacy of MADDENING CROWD:
NON STOP CIRCUS:
May the approvals come quickly and save cancer patient's lives.
IF only just a Followup re ongoing discussions re COMBO trials
WILL then OPEN the FLOODGATES for Market Place
to DROWN out BOTH DARK Force FUDSTERS!
and Naysaying DUBIOUS Machiavellian longs!
All one has to look at is NWBO’s CEO Linda Powers MONUMENTAL REALIZED Long Term GAINS in Cognate BioServices and obviously that of Sawston: LONG TERM VISIONARY along with the necessary legal prowess to protect what she has uncovered from that of vultures whether Big Pharma or ILLegal Market Manipulating Naked Shorts using various tools from their Weapons of Mass Destruction wanting NWBO’s carcass in the last few years. STATED in Mid 2019 but Identified & posted in 2015 The above CONCLUSIVELY demonstrates NOBODY here or Yahoo etc listened to deep demonstrated professional FRONTLINE EXPERIENCE vs NOISE on media’s such as this: forget about LOGIC It is for way too many A POPULARITY CONTEST[! At this LATE STAGE very easy to see those on the DEVASTATING wrong side of the cratering NWBO & hundreds of OTHERS that experienced the SAME are doing a REVERSAL to try to undo? their Irreparable damage to get back to some limelight: very OBVIOUS to those who may have those abilities which has not been seen since 2014-2015 in the biggest historical bull stock market. Only when one gets it RIGHT with DOCUMENTATION & LOGIC vs HERE SAY on the first try with RESULTS does it matter!
The only saving grace is that of the
RELENTLESS, UNSTOPPABLE, BACKSTOPPING, INSCRUTABLE CEO Linda F. PowerS with her team
and that of 3 other FEMME PHENOMS (+ 4th: ASIA) against The World:
(7 TITANIC SPOOFING defendants assisted by COLLUSION by entrenched Wall St establishment, Novocure & BIG RX AND having to CHANGE INDUSTRY REGULATORY GUIDELINES! for the
New Era of Personalized EFFICACIOUS & SAFE Immuno Oncology
to deal with both Operable & INoperable Solid Tumors https://investorshub.advfn.com/boards/replies.aspx?msg=172268756
From THRICE near ASHES to The PHOENIX
DiFFERENT STROKES for DIFFERENT FOLKS
The latest MRK STRATEGIC Overview AUG 3, 2023
BOTH Merck & Regeneron will be CORE Complementary NWBO COLLABORATORS in the
New Era of Personalized Immuno Oncology.
Merck has been addressed by me in many posts since 2019 and most recently in:
[color=red]WATERSHED Revelation today MERCK citing: Exciting New Landscape[ [color=red][/color]
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172525806
DIFFERENT STROKES for DIFFERENT FOLKS
Best comprehensive Overview Thanks Margaret Monsoon & Peter Graves
Here is an amazing compilation of Celebrities fallen by GBM
http://www.ranker.com/list/famous-people-who-died-of-brain-tumor/reference
Underscoring SEEING in 2014 WAY AHEAD of Maddening Crowd even WAY BEYOND ExWan
AND regardless it is yet one of a TROVE of EVIDENCE re the PERILS of worshipping a wide band of Flip FLOPPERS that ADDS to Fudders & the NWBO ALBATROSS since 2015!
Have NOT seen ANY reliable EVIDENTIAL PROOF since 2015 by those on the WRONG SIDE OF HISTORY PERIOD BOTH FUDSTERS & Credulous Longs?.
So since 2014 on this board there is conclusive evidence it has ALL focused about
maintaining King/Queen status on the crumbled NWBO mountain:
ie POPULARITY via DT modius operandi which I have seen BOATLOADS of for 40 years!
Totally Agree with BrightBoy as my encounters since 2015-2018 were intentionally brief by my design .
Same for PoorMan & the entire Brigade of sophisticated SPINSTERS, relentless, ruthless
monetary MERCENARIES exemplified by the 7 TITANIC SPOOFING Defendants: early Dec 2022 my reaction inside CEO Linda PowerS mindset: God willing I would like this to proceed to RICO
Back to above commentary re Bright Boys
That entire Brigade, especially
ExWan has lived up to my many replies back in 2015-2018
It's 24/7/365.......
even pursued by ExWan onto Biotech Values iHub board another TOXIC Superfund Site controlled by DARK Forces based on numerous encounters with the CZAR there
Bottomline: $ too good & can't leave for UK
I do see an upcoming different Ball & Chain of non remuneration.
DIFFERENT STROKES for DIFFERENT FOLKS
Thank you for the needed ELUCIDATIONS!
It was NON Starter from the very inception.
Threader would like to recast but DIE WAS CAST since 2014-2015
There likely will be MORE! of his SPIN variationS
No one knows : NOT even the JUDGE !
which you’ve already assumed that position by your reply
A SNIPPER Target practicing ENDLESSLY but who never got it RIGHT.
WASTE of anyone’s time:
Not falling into your devious entrapment modi’s operandi of getting one in JAIL
which you instigated in multiple ways in 2019
So you could be held UNACCOUNTABLE with your 50 foot BLIZZARD
Throwing others under The Bus.
DIE has been CAST since 2014.
Questions are RAMPANT,
RIGHT Answers especially to OPEN ENDED legal proceedings questions are hither & thither.
To ask underscores your SAME OLE SAME OLE seen & demonstrated for last 9 years.
This has been the Amazon jungle.
So when hiking WITHOUT buying a Garmin hiking GPS (which I have used extensively) can be devastating as history has shone amply HERE.
Being EQUIPPED with the RIGHT tools & EXPERTISE are key
Thanks DStock (COLUMBO vs pictured, fallen Sherlock Napoleon DT)
Not paying attention to history that matters (why shs are sub basement!) has CONSEQUENCES.
NWBO’s EPIC is REPLETE with the large cast of DUBIOUS even MACHIAVELLIAN characters
UNDERSTANDING the ones that matter and their Strengths & Weaknesses is KEY
NO ONE on any message board has demoed with any documentation
Prime example is this message board PERIOD: thought it was the best but clearly it has been on the WRONG SIDE of 8+ years of history! Replete with BLAME GAME PSYCHOLOGY along with tons of deflections redirect and excuses galore emblematic of The MORON!
Here is how it BEGAN as documented EVIDENCE on a FEW Major fronts of BUSHELS until his sticky of why the above earned appellations of the key neophyte…
This is only one of MANY SCORES in the overflowing documentation of a 9 year debacle of being on the WRONG side of NWBO’s stock price history of a round trip from $3-12 to FIFTEEN CENTS….
that the naive & gullible followed the Pied Piper’s bully pulpit diarectic war of words(DT)
Before CrashOveride applies or accepts one really should CONSULT privately with FORMER moderators of the Pro's & Con'sof being one:
Astravaka
Know Fear
Doc_Logic
Bala
Star Mutual Fund Mgrs FAILURE + NWBO
#DISRUPTOR #CANCER $NWBO
— maverick_1 (@maveric92283613) September 1, 2023
Collaborators: $MRK $REGN $BMY $GILD $AMGN $RHHBY $AZN
Frmr TECH Disrptrs $TSLA $AAPL $NVDA $MSFT $GOOG $Fund FLOPS: Woodford & FLOPPERhttps://t.co/zkAes6hDYohttps://t.co/0hB6AZdTtIhttps://t.co/ePaIpab95g
10% NWBO RAIDER &
292K UK'ers $LOST reFLOPPER
Interesting but NOTHING!
Mugs57 covers lots of bases since 2009
https://investorshub.advfn.com/boards/profileb.aspx?user=169585
FACT In a quickie 2 cos represent 62% of all Mugs57 iHub posts
BOTH Went Chapter 7 Bankruptcy filing
Why anyone bothers tells ALL.: unable to discern
AND I have encountered The BOATLOADS of peddlers to KNOW IT ALLS imposters
that plunders one retirement accounts( even here!) to being 4X INDICTED & $ flowing in!
DIFFERENT STROKES for DIFFERENT FOLKS
Volatile: Tinkering for Pennies vs BOATLOADS soon.
#DISRUPTOR #CANCER $NWBO
— maverick_1 (@maveric92283613) August 31, 2023
Collaborators: $MRK $REGN $BMY $GILD $AMGN $RHHBY $AZN
Frmr TECH Disrptrs $TSLA $AAPL $NVDA $MSFT $GOOG Frmr MedDev Disrptrs: $MDT $ABT $ZBH $BSX
Great ADVICE: Tinkering for Pennie’s for BOATLOADShttps://t.co/uQ6atWEEDThttps://t.co/mLjEnEHsay
ONE of MANY BIG WaveS converging for MOTHERLODE $NWBO
and obliteratingTSUNAMI
for New Era of Personalized Immuno Oncology
BOTH EFFICACIOUS & SAFE
for BOTH Extending & SAVING LIVES!
CANCERS+ in Operable & INoperable Solid Tumors in a World of CHAOS
So yes ... NWBO has the option to be fast tracked and get approval way faster than the 150 day route. pic.twitter.com/EnYIqhbHYR
The only saving grace is that of
the UNSTOPPABLE, BACKSTOPPING, INSCRUTABLE
CEO Linda F. PowerS with her team
and that of at least 3 other FEMME PHENOMS against The World:
(7 TITANIC SPOOFING defendants assisted by collusion by entrenched Wall St establishment, BIG RX + Novocure, AND having to CHANGE INDUSTRY REGULATORY GUIDELINES!
for the New Era of Personalized EFFICACIOUS & SAFE Immuno Oncology
to deal with both Operable & INoperable Solid Tumors.
From THRICE near ASHES to The PHOENIX
DiFFERENT STROKES for DIFFERENT FOLKS
UNable to see SPOOFING trial go to RICO as I did 8 mos ago:
UNDERSCORES what the “retail investment crowd” FUMBLES on this EPIC!
When one after ALL the major inflection points SEEN since 2015, which I am
FED UP with the demonstrated INEPTITUDE!, do not factor the underlying
motivations of BOTH the Plaintiff and the DEFENDANTS…..ramify the desperate need not of continual need for NWBO blood transfusions which I have donated profusely and against
too many high horses with their own convoluted agenda here (the Brigade of DARK FORCES,
Naysers only seeing to tip of their bloodied noses, and the repugnant, pugnacious so called Long:
FAILURES) ALL dealing with picayune on ISSUES GALORE since 2015 & clearly way beyond their pay grades, let alone experience for their SELF INFLICTIONS & playing The BLAME GAME.
The only saving grace is that of the UNSTOPPABLE, BACKSTOPPING, INSCRUTABLE
CEO Linda F. PowerS with her team and that of 3 other FEMME PHENOMS against The World
(7 TITANIC SPOOFING defendants assisted by collusion by entrenched Wall St establishment, BIG RX + Novocure, AND having to CHANGE INDUSTRY REGULATORY GUIDELINES!
for the New Era of Personalized EFFICACIOUS & SAFE Immuno Oncology to deal with both
Operable & INoperable Solid Tumors.
From THRICE near ASHES to The PHOENIX
DiFFERENT STROKES for DIFFERENT FOLKS
Resus:
Orders were Both Submitted &:TRANSACTED
For reasons beyond my knowledge they somehow did not connect with the main feed for composite real time reporting that one sees with the proper system
Hope that helps
Unless the OTC BB TRADE rules & regulations changed:
Trades after 4:00 pm are
One’s that were for whatever reason not submitted when done during Mkt hrs
So it has to be accounted for.
So one should not let that “head fake seep into one’s mindset”
Not easy for many tho.
Understanding WHAT to do & WHEN can be LIVE or DIE vs DARK Forces!
HOLD as MUCH as LONG as you CAN to WIN: too long for some re
SPOOFING expected RICO since Dec2022
From recollection
65 is 1st Resistance
69 is 2nd Resistance
To let populace get a sense that there is much much more than yesterday's PR:
— maverick_1 (@maveric92283613) August 30, 2023
Momentum can be fleeting & needs some elements of sustenance given MKT Mkr Manipulations.
Don't think at this LATE Stage it will bite us from behind.
FACT::Got a Sticky 1st to post a BASIC
maverick_1
Re: maverick_1 post# 241197
08/27/2019 1:59:19 PM
Fewer than 10% of glioblastoma patients survive past five years of an initial diagnosis, with most living less than a year. Despite advances in many other cancers, survival rates are getting worse for brain cancer patients, according to the latest Annual Report to the Nation on the Status of Cancer from the National Cancer Institute, CDC, and others. https://seer.cancer.gov/report_to_nation/
It took the Regulators TOO LONG!
maverick_1 Wednesday, 07/03/19
Re:sentiment_stocks post# 235292
Post #
235296
of 235353
This would fit NWBO circumstances: FDA’s Real World Evidence (RWE)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149721271
------------------------
maverick_1 Member Level Tuesday, 07/02/19 11:59:14 PM
Re: sentiment_stocks post# 235292
Post #
235295
of 235353
Sentiment: Apparently you missed the contents......
----------------
maverick_1 Member Level Wednesday, 06/26/19 03:04:25 PM
Re:flipper44 post# 234687
Post # of 234710
REAL TIME ONCOLOGY REVIEW ONLY FOR FDA APPROVALS w/Mktg application::
Music is too Foreign ....
Instead of your
Peter Davis : Big Thanks for a respected 3rd Party source which gets me back to what I posted in too many posts.
Regardless it is ALL big welcome UK MHRA CHANGE
AND hopefully we don"t have another comparable episode.
BTW:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172719628
Hate to say it but this did not pass my smell test (see prior posts).
Fortunately I sold ALL & took a load vs a LARGE one.
Was going to post more about it .
Thank you Peter
AND that's from one whoBOTH truly plies into UK HC developments and is domiciled there .
So even a PM exchange in last few minutes with Hoffman understands my viewpoint and agrees.
AND I have never been dogmatic or argumentative.
Apologies to all.
Why not make it simple:
MHRA in that PR should have been clearer:
why they, not me, include the MAA clause
AND state
Only for NEW Trials
OR better yet:
Not Applicable to Pre Existing Marketing Approval Application
My MISREAD on Bureaucratic legalese & protocols
Asta why no one else make that assertion???
Your revealing hip shot OVERSIGHT
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172717232
BTW contained & BOLDED in post re Newfound Acceleration @MHRA:
The MHRA plans to shorten the timeline for the completion of an application review to a maximum of 30 days, and a maximum of 10 calendar days to make a final decision upon receipt of further information.
Not Semantics
Social Media DESTROYING Society WW!
LIVES don't matter to FUDSTERS just $
DIFFERENT STROKES for DIFFERENT FOLKS
In the OPEN: Wholesale Streamlining of UK MHRA re EMA Clinical Trials contains Marketing Application Approval (MAA)
Typical Exwan Picayune FUDster:
Hoffman Pls review the FUDSTER re MAA & wholesale speedup even tho TRIAL:
So there exists
1)UK MAA & FDA by Halloween - THSGVG
2)2 or more DealS with BIG $ & favorable milestone payments & royalties
3)Legal Short covering
4) MOTHERLODE
5) UPLIST NASD NYSE or LONDON
6) CALENDAR of appearances thru Dec 2023
7) EXPECT lots of WS coverage
8) Institutional STAMPEDE can only be accommodated with an Offering
WHO KNOWS $ SHR
9)SPOOFING JACKPOT……..
95% have gone FROM EXASPERATINGLY DEPRESSED to the above“NIRVANA?”
BTW I didn’t out of blue come up with
UNSTOPPABLE BACKSTOPPING based on dreams: My senses have never failed me.
DIFFERENT STROKES for DIFFERENT FOLKS
So as IRONY &FATE is displaying:
2015 ADVISED both Linda & Les to BE as SILENT as legally possible
DEC 2022 to Present: MENTALLY Challenging in total silence by NWBO to deduce what is happening
from Thrice near ASHES to HOW to attain The Phoenix.
It began with the early Spring post:
Seeing the beginnings of Going it ALONE
AND I have always been forthright, in DE Stressing by journaling.
When I have some time I go back even multi decades for memories, reflections & introspections.
DIFFERENT STROKES for DIFFERENT FOLKS
Newfound Expeditiousness in UK MHRA’s in Approvals, transparency ETC
LIKELY WHY IT IS NO COINCIDENCE NWBO Communique SAME DAY!
As iwasadiver (Greg Zivic) I don’t believe it was just a coincidence!
This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stagesThe MHRA hopes this new framework “will remove obstacles to innovation” and “streamline the regulation of clinical trials” amongst other things. These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21.
The MHRA plans to shorten the timeline for the completion of an application review to a maximum of 30 days, and a maximum of 10 calendar days to make a final decision upon receipt of further information.
Furthermore, the UK is now implementing a legislative requirement to publicly register clinical trials and share summary results with any research participants. The new framework will introduce a legal mandate to register a trial in the World Health Organisation (WHO) public register. Researchers will also have to publish a summary of results within 12 months of the end of the trial. The press release stated that sharing trial findings with participants in a, yet to be defined, “timely manner and suitable format” will also be required by law
The agency reports that, in the pilot phase, these revisions halved the approval times for studies and cut the time from application to recruiting the first patient by 40 days. The new regulation has been designed to embed these changes. .
The new rules are particularly relevant as new trends and innovation are taking precedence in clinical trial design. MHRA hopes to keep more modern trial designs in mind, such as decentralised clinical trials, with these developments.
In a press release, Marc Bailey, MHRA’s Chief Science and Innovation Officer, said “Our world-first Covid-19 approvals showed how important it is to ensure that regulation is flexible and agile. This overhaul of the clinical trials legislation will do just this – it will move us away from a one-size-fits-all approach to the regulation of clinical trials and help to streamline approvals by removing granular and duplicative regulatory requirements”.
The news arrives after a 2022 The Association of the British Pharmaceutical Industry (ABPI) report said the UK’s collapsing clinical research industry was collapsing. Between 2017 and 2021, the number of industry-led Phase III trials initiated fell by 48%, as per the report. In an announcement after the MHRA’s release, the ABPI’s Chief Executive, Ricard Torbett responded positively to the UK regulator’s changes. He said, “It’s great to see the MHRA taking forward these important changes to UK clinical trials regulation centred on patient safety and the benefits of participating in research”.
https://www.pharmaceutical-technology.com/news/mhra-revamps-uk-clinical-trial-regulation-with-the-promise-of-faster-timelines/.
DIFFERENT STROKES for DIFFERENT FOLKS
Great Britain approves subcutaneous Tecentriq weeks ahead of expected US decision
Nicole DeFeudis
Editor
Patients in Great Britain who take IV Tecentriq now have a quicker option.
The country’s regulatory authority has approved a subcutaneous version of atezolizumab, better known as Roche’s blockbuster immunotherapy Tecentriq. The new version takes just seven minutes to administer, as opposed to 30 to 60 minutes for the IV formulation, Roche announced on Tuesday.
The news comes weeks ahead of an expected decision in the US on Sept. 15, executives said on the company’s recent Q2 earnings call per an AlphaSense transcript. In Great Britain, Tecentriq SC’s label covers all the same indications as the IV formulation and will be available “in the coming weeks,” a spokesperson told Endpoints News. The EU’s regulatory authority is currently considering the drug’s use, including in Northern Ireland.
Tecentriq SC’s approval marks its first worldwide, and the first subcutaneous PD-L1 approval in Great Britain, Roche said. The checkpoint inhibitor was first approved in the US in 2016 for [certain metastatic lung cancer patients, and has since expanded to a variety of cancers, including bladder, breast and liver cancer. The drug generated roughly $4.2 billion in 2022 sales, representing Roche’s fourth-highest seller.
“[Giving Tecentriq subcutaneously now offers patients a faster and more flexible treatment option and can free up resources for healthcare systems, while maintaining its established safety profile,” Roche’s CMO and head of global product development Levi Garraway said in a news release.
Rival drugmakers are also working on subcutaneous versions of their blockbuster PD-L1s, including Merck,which recently announced its Keytruda SC candidate met the co-primary endpoints in an ongoing Phase III trial in certain non-small cell lung cancer patients. Bristol Myers Squibb’ssubcutaneous version of Opdivo is currently in Phase III.
https://endpts.com/roches-subcutaneous-tecentriq-wins-approval-great-britain-approval-weeks-ahead-of-expected-us-decision/
DIFFERENT STROKES for DIFFERENT FOLKS
Highlights of EPIC, AFRAUDSTEIN
singled ME here out of thousands
Why not "The pictured Sherlock Holmes" or Pyrhonian ETC
#DISRUPTOR #CANCER $NWBO
— maverick_1 (@maveric92283613) August 29, 2023
Collaborators: $MRK $REGN $BMY $GILD $AMGN $RHHBY $AZN
Frmr TECH Disrptrs $TSLA $AAPL $NVDA $MSFT $GOOG
Frmr MedDev Disrptrs: $MDT $ABT $ZBH $BSX
Highlights of This EPIChttps://t.co/S9mhmc5RvA
A FRAUDSTEIN
ONLY singled ME out of thousands of iHubbers
Seeking Alpha released Oct 2015 Phase V which was a Guillotine event for NWBO which I labelled as a Tome of a Tomb full of FALSEHOODS.
AND given the precariousness of 18 months of SEC deliberations which were finalized last week the first big up day from 41cts ruling treatment of sizable hedge funds: CITADEL & their Balance Sheet like near banks, it is no surprise that Seeking Alpha would REJECT.
DIFFERENT STROKES for DIFFERENT FOLKS
The GUISE or pretext used is you should have a balanced diversified portfolio.
Are you aware of the FACT I posted many, many years ago that
Goldman Sachs gave up it's role as The Prime Broker Lending Shares to BORROW TO HEDGE FUNDS
To FIDELITY!
Also the Stock Lending Dept is consistently the most reliable & KEY PROFIT center for the industry: I learned that in the early 1980's by meeting the head of Pershing a key subsidiary now of Bank of NY Mellon
https://en.wikipedia.org/wiki/Pershing_LLC?wprov=sfla1
So that is a key part of the monetary collusion of Wall St Prime Brokers to that of Citadel
AND ones shares somehow can be loaned out 2-3x which explains the examples posted earlier pre open today where one NASD co had 1.6 Mln shs out traded 46 Mln in one day
AND linked that to FINRA & DTC
where NAKED SHORTING data is protected and done in The DARK which is just last week SEC after 18 mos are treating this Giants like near banks:
Citadel, Susquehanna ETC
DIFFERENT STROKES for DIFFERENT FOLKS
dstock07734
07/15/23 9:54 PM
#610212 RE: Bright Boy #610164
BB,
From the news, it says
Unlike most large drug companies, Regeneron doesn’t use mergers and acquisitions to fortify its business. In fact, over its nearly 35-year history, the company has never purchased another public drug developer.
But Regeneron made an exception to a company called Checkmate Pharmaceuticals simply because the company has a drug called Vidutolimod which can activate anti-tumor T cell responses. I suspect basically it can make t cells reach tumor sites so that all the weapons from Regeneron's arsenal such as checking point inhibitors, bispecific antibodies can work.
https://www.biopharmadive.com/news/regeneron-checkmate-cancer-drug-first-acquisition/622306/
Take a look at the results from the clinical trial on the combination with Keytruda on which Regeneron put so much hope.
https://classic.clinicaltrials.gov/ct2/show/NCT04698187?cond=NCT04698187&draw=2&rank=1;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799774/pdf/2998.pdf
The combination of vidutolimod and pembrolizumab had a manageable
safety profile, and durable responses were observed in 25% of patients, with tumor regression in both
injected and noninjected lesions, including visceral lesions.
Recall in the Direct trial, if I remember correctly, 2 out of 5 melanoma patients were still alive after five years.
From the perspective of a lay person, I didn't find the results from Regeneron's combo trial were impressive at all.
Having a partnership with DCVax-L can certainly make Regeneron's dream of becoming a leader in the new era of immuno-therapy. With DCVax-L as the center, I suspect all the ammo from Regeneron can maximize its efficacy
maverick_1
08/03/23
#616833 RE: maverick_1 #616110
New Era of Immuno Oncology dealing with Solid (Hot/Cold & Agnostic ) Tumors
The complimentary synergy & expanding TRIO+ partners/combo’s ETC
At the center of that universe: NWBO + Poly ICLC (“King” of TKO’s)
Complimentary Financial Partner the Modern Day Rip Van Wrinkle that juvenated mid Hudson Valley Tarrytown, NY in last 20 yrs: REGENERON
is looking to REjuvenate & propeller itself into NEW ERA of Immuno Oncology
Listen to REGN 2Q CC Aug 3 NOW ON!
https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2023-earnings-conference-call
DIFFERENT STROKES for DIFFERENT FOLKS
2:15 PM 4.4 Mln shs, 47Mln Short